Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2025) 110 P251 | DOI: 10.1530/endoabs.110.P251

ECEESPE2025 Poster Presentations Bone and Mineral Metabolism (112 abstracts)

A case of heterozygous PTHLH deletion causing brachydactyly type E2

Ping Li 1 , Jie Xing 1 & Meng Zhang 1


1the Second Hospital of Jilin University, Department of Developmental Pediatrics, Changchun, China


JOINT899

Background: Brachydactyly type E (BDE), a rare skeletal dysplasia (OMIM: 113300), is characterized by metacarpal/metatarsal shortening and variable skeletal anomalies. BDE2 (OMIM: 613382), a distinct subtype, arises from pathogenic variants in the PTHLH gene (12p12. 1-p11. 22), which regulates endochondral ossification via parathyroid hormone-related protein signaling. Heterozygous loss-of-function variants in PTHLH are associated with a characteristic skeletal pleiotropy, classically manifesting as severe generalized bilateral brachydactyly, proportionate short stature, pectus carinatum deformity, and radiologically confirmed premature epiphyseal fusion.

Clinical Case: A 5-year-7-month-old girl presented with symmetrical brachydactyly. Her height(115 cm, 50th percentile), weight(19 kg, 50th percentile) and neurodevelopment were age-appropriate. Her hand radiographs showed dysplastic epiphyses in all digits, and her bone age was 6 years old with mild thoracolumbar scoliosis (Cobb angle 10°). Familial evaluation revealed no brachydactyly or skeletal anomalies. Trio-based whole-exome sequencing (WES) identified a de novo 1. 90 Mb heterozygous deletion at 12p12. 1-p11. 22 (GRCh37: chr12:26, 217, 430-28, 122, 427), encompassing PTHLH exons 3-4. Quantitative PCR confirmed the proband-specific deletion, absent in parental genomes. Decipher/ClinVar databases classified this CNV as pathogenic for BDE2. During 3-year follow-up, scoliosis remained stable (Cobb angle 10°), with height growth velocity of 6 cm/year. She did not yet exhibited signs of pubertal development at eight and half years old.

Conclusion: This study expands the mutational spectrum of BDE2 by identifying the PTHLH intragenic deletion. The absence of familial transmission supports de novo dominance. Notably, preserved stature and non-progressive scoliosis contrast with typical BDE phenotypes, highlighting the broad phenotypic spectrum of PTHLH-related skeletal dysplasias, and necessitating integrated genomic diagnostics to delineate genotype-phenotype correlations. Despite preserved anthropometric parameters (height Z-score: 0. 0) and age-appropriate neurodevelopment, structured surveillance protocols remain critical to monitor potential skeletal sequelae, including scoliosis progression and metaphyseal dysplasia.

Volume 110

Joint Congress of the European Society for Paediatric Endocrinology (ESPE) and the European Society of Endocrinology (ESE) 2025: Connecting Endocrinology Across the Life Course

European Society of Endocrinology 
European Society for Paediatric Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches